New insights into the efficacy of SR-16234, a selective estrogen receptor modulator, on the growth of murine endometriosis-like lesions
New insights into the efficacy of SR-16234, a selective estrogen receptor modulator, on the growth of murine endometriosis-like lesions
复制标题
关于选择性雌激素受体调节剂 SR-16234 对小鼠子宫内膜异位症样病变生长功效的新见解
DOI:
10.1111/aji.13023
复制
发表时间:
2018
影响因子:
3.6
通讯作者:
Harada Tasuku
中科院分区:
文献类型:
--
作者:
Khine Yin Mon;Taniguchi Fuminori;Nagira Kei;Nakamura Kazuomi;Ohbayashi Tetsuya;Osaki Mitsuhiko;Harada Tasuku
ProblemTo evaluate the effects of SR‐16234 (SR), a selective estrogen receptor modulator (SERM), on murine endometriosis‐like lesions.Method of studyBALB/c mice (n = 53) were used to establish the murine endometriosis model. Ovariectomized, estradiol replaced, 6‐week‐old murine endometriosis model were injected with lipopolysaccharide (LPS) with or without SR (1 mg/kg/d) or vehicle, over a period of 4 weeks. Upon treatment completion, the endometriosis‐like lesions that developed in the abdominal cavity of mice were counted, measured, and collected. Gene expression of inflammatory cytokines and estrogen receptor (ER) in the lesions was assessed by real‐time RT‐PCR. Immunohistochemical analysis was used to evaluate the effect of SR on cell proliferation, angiogenic activity, inflammation, and NF‐κB phosphorylation.ResultsTreatment with SR significantly reduced the total number and size of lesions per mouse without inducing endometrial growth. In addition, SR downregulated LPS‐enhancedVegf, Il‐6, Ptgs‐2,andCcl‐2and ER mRNA expression in endometriosis‐like lesions. Immunohistochemical analysis demonstrated a decrease in percentage of positive cells of Ki67, and intensity and rate of positive cells of ERα, CD3, F4/80, PECAM by SR treatment. SR also decreased the expression of NF‐κB p65 and phospho‐NF‐κB p65.ConclusionSR has a regressive effect on the development of murine endometriosis‐like lesions.